Advanced search
Publication Cover
Climacteric Volume 18, 2015 - Issue 6
Submit an article Journal homepage
455
Views
30
CrossRef citations to date
0
Altmetric
Original Article

MsFLASH participants’ priorities for alleviating menopausal symptoms

J. S. CarpenterScience of Nursing Care, School of Nursing, Indiana University, Indianapolis, IN; Correspondence[email protected]
,
N. F. WoodsBiobehavioral Nursing, University of Washington, Seattle, WA;
,
J. L. OtteScience of Nursing Care, School of Nursing, Indiana University, Indianapolis, IN;
,
K. A. GuthrieFred Hutchinson Cancer Research Center, Seattle, WA;
,
C. HohenseeFred Hutchinson Cancer Research Center, Seattle, WA;
,
K. M. NewtonGroup Health Research Institute, Seattle, WA;
,
H. JoffeHarvard Medical School, Department of Psychiatry, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Boston, MA;
,
L. CohenCenter for Women's Mental Health; Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital, Boston, MA;
,
B. SternfeldDivision of Research, Kaiser Permanent Medical Program of Northern California, Oakland, CA;
,
R. J. LauDepartment of Obstetrics and Gynecology, School of Medicine, Indiana University, Indianapolis, IN;
,
S. D. ReedDepartments of Obstetrics/Gynecology and Epidemiology, University of Washington School of Medicine, Seattle, WA;
&
A. Z. LaCroixDepartment of Preventive Medicine, University of California San Diego, San Diego, CA, USA
 show all
Pages 859-866 | Received 06 Jun 2015, Accepted 10 Aug 2015, Published online: 30 Oct 2015

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

J. K. Prague. (2021) Neurokinin 3 receptor antagonists – prime time?. Climacteric 24:1, pages 25-31.
Read now
C. A. McCormick, A. Brennan & M. Hickey. (2020) Managing vasomotor symptoms effectively without hormones. Climacteric 23:6, pages 532-538.
Read now
L. Honermann, L. Knabben, S. Weidlinger, N. Bitterlich & P. Stute. (2020) An extended Menopause Rating Scale II: a retrospective data analysis. Climacteric 23:6, pages 608-613.
Read now
Anna Szeliga, Adam Czyzyk, Agnieszka Podfigurna, Andrea R. Genazzani, Alessandro D. Genazzani & Blazej Meczekalski. (2018) The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications. Gynecological Endocrinology 34:11, pages 913-919.
Read now
J. K. Prague & W. S. Dhillo. (2017) Neurokinin 3 receptor antagonism – the magic bullet for hot flushes?. Climacteric 20:6, pages 505-509.
Read now
Myra S. Hunter & Leroy C. Edozien. (2017) Special Issue on biopsychosocial perspectives on the menopause. Journal of Psychosomatic Obstetrics & Gynecology 38:3, pages 159-160.
Read now
Martha Hickey, Kathleen Riach, Reza Kachouie & Gavin Jack. (2017) No sweat: managing menopausal symptoms at work. Journal of Psychosomatic Obstetrics & Gynecology 38:3, pages 202-209.
Read now

Articles from other publishers (23)

Jerilynn C. Prior, Andrea Cameron, Michelle Fung, Christine L. Hitchcock, Patricia Janssen, Terry Lee & Joel Singer. (2023) Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial. Scientific Reports 13:1.
Crossref
Marcie K. RichardsonNina CoslovNancy Fugate Woods. (2023) Seeking Health Care for Perimenopausal Symptoms: Observations from The Women Living Better Survey. Journal of Women's Health 32:4, pages 434-444.
Crossref
Julia K Prague. (2023) Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms. The Lancet.
Crossref
Qinying Lan, Martha Hickey, Michelle Peate & Jennifer L. Marino. (2023) Priorities for alleviating menopausal symptoms after cancer. Menopause 30:2, pages 136-142.
Crossref
Sarah Witkowski, Rose Evard, Jacquelyn J. Rickson, Quinn White & Lynnette Leidy Sievert. (2023) Physical activity and exercise for hot flashes: trigger or treatment?. Menopause 30:2, pages 218-224.
Crossref
Katrina M. Moss, Gita D. Mishra, Efrosinia O. Krejany & Martha Hickey. (2022) What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy. Gynecologic Oncology 167:1, pages 58-64.
Crossref
Chen Zhu, Natalie Thomas, Shalini Arunogiri & Caroline Gurvich. (2022) Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptoms. Maturitas.
Crossref
Martha Hickey, Myra S Hunter, Nanette Santoro & Jane Ussher. (2022) Normalising menopause. BMJ, pages e069369.
Crossref
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment 1 10 .
Andrea R Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update 27:6, pages 1115-1150.
Crossref
Bobae V. Kim, Stamatina Iliodromiti, Monica Christmas, Robin BellSarah Lensen & Martha Hickey. (2020) Protocol for development of a core outcome set for menopausal symptoms (COMMA). Menopause 27:12, pages 1371-1375.
Crossref
Susan D. Reed, Andrea Z. LaCroix, Garnet L. Anderson, Kristine E. Ensrud, Bette Caan, Janet S. Carpenter, Lee Cohen, Susan J. Diem, Ellen W. Freeman, Hadine Joffe, Joseph C. Larson, Susan M. McCurry, Caroline M. Mitchell, Katherine M. NewtonBarbara Sternfeld & Katherine A. Guthrie. (2020) Lights on MsFLASH: a review of contributions. Menopause 27:4, pages 473-484.
Crossref
Julia K Prague, Ali Abbara, Alexander N Comninos, Channa N Jayasena, Claire E Higham, Jo Adaway, Brian G Keevil, Johannes D Veldhuis & Waljit S Dhillo. (2020) Neurokinin 3 Receptor Antagonists Do Not Increase FSH or Estradiol Secretion in Menopausal Women. Journal of the Endocrine Society 4:2.
Crossref
S Iliodromiti, W Wang, MA Lumsden, MS Hunter, R Bell, G Mishra & M Hickey. (2019) Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology 127:3, pages 320-333.
Crossref
Lisa Jean Taylor-Swanson, Kenneth Pike, Ellen Sullivan Mitchell, Jerald R. HertingNancy Fugate Woods. (2019) Self-awareness and the evaluation of hot flash severity: observations from the Seattle Midlife Women's Health Study. Menopause 26:5, pages 476-484.
Crossref
Julia K. Prague, Rachel E. Roberts, Alexander N. Comninos, Sophie Clarke, Channa N. Jayasena, Pharis Mohideen, Vivian H. Lin, Theresa P. Stern, Nicholas Panay, Myra S. Hunter, Lorraine C. Webber & Waljit S. Dhillo. (2018) Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action. Menopause 25:8, pages 862-869.
Crossref
Nancy Fugate Woods & Wulf Utian. (2018) Quality of life, menopause, and hormone therapy: an update and recommendations for future research. Menopause 25:7, pages 713-720.
Crossref
Julia K. Prague & Waljit S. Dhillo. (2017) Treating hot flushes with a neurokinin 3 receptor antagonist. Oncotarget 8:63, pages 106153-106154.
Crossref
Tatjana Gazibara, Selmina Nurkovic, Nikolina Kovacevic, Ilma Kurtagic, Biljana Rancic, Sanja Radovanovic, Branislav Milosevic, Milan Terzic & Jelena Dotlic. (2017) Factors associated with sexual quality of life among midlife women in Serbia. Quality of Life Research 26:10, pages 2793-2804.
Crossref
Janet S. Carpenter, Giorgos Bakoyannis, Julie L. Otte, Chen X. Chen, Kevin L. Rand, Nancy Woods, Katherine Newton, Hadine Joffe, JoAnn E. Manson, Ellen W. Freeman & Katherine A. Guthrie. (2017) Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales. Menopause 24:8, pages 877-885.
Crossref
Julia K Prague, Rachel E Roberts, Alexander N Comninos, Sophie Clarke, Channa N Jayasena, Zachary Nash, Chedie Doyle, Deborah A Papadopoulou, Stephen R Bloom, Pharis Mohideen, Nicholas Panay, Myra S Hunter, Johannes D Veldhuis, Lorraine C Webber, Les Huson & Waljit S Dhillo. (2017) Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet 389:10081, pages 1809-1820.
Crossref
Katherine M. Newton. (2017) We still have a long way to go. Menopause 24:1, pages 3-4.
Crossref
Janet S. Carpenter, Salene M. W. Jones, Christina R. Studts, Julia R. Heiman, Susan D. Reed, Katherine M. Newton, Katherine A. Guthrie, Joseph C. Larson, Lee S. Cohen, Ellen W. Freeman, R. Jane Lau, Lee A. Learman & Jan L. Shifren. (2016) Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis. Archives of Sexual Behavior 45:8, pages 1897-1905.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.